Silencing of Lactotransferrin expression by methylation in prostate cancer progression

Cancer Biology and Therapy

Volumn 6, Issue 7, 2007, Pages 1088-1095

  Shaheduzzaman, Syed ^a   Vishwanath, Anu ^a   Furusato, Bungo ^b   Cullen, Jennifer ^a   Chen, Yongmei ^a   Bañez, Lionel ^a   Nau, Martin ^e   Ravindranath, Lakshmi ^a   Kim, Kee Hong ^a   Mohammed, Ahmed ^a   Chen, Yidong ^d   Ehrich, Mathias ^f   Srikantan, Vasantha ^a   Sesterhenn, Isabell A ^b   McLeod, David G ^a,c   Vahey, Maryanne ^e   Petrovics, Gyorgy ^a   Dobi, Albert ^a   Srivastava, Shiv ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e WRAIR   (United States)

^f SEQUENOM INC   (United States)

Author keywords

Chemoprevention; Downregulation; LTF; Methylation; PSA doubling time

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; LACTOFERRIN; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ANALYTICAL EQUIPMENT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN LNCAP; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CPG ISLAND; CULTURE MEDIUM; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION;

EID: 42449093747     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.7.4327     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, and Thun MJ. Cancer statistics CA. Cancer J Clin 2007; 57:43-66.
2. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310:644-8.
3. Isaacs W, Kainu T. Oncogenes and tumor suppressor genes in prostate cancer. Epidemiol Rev 2001; 23:36-41.
4. Moul JW, Merseburger AS, Srivastava S. Molecular markers in prostate cancer: The role in preoperative staging. Clin Prostate Cancer 2002; 1:42-50.
5. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003; 349:366-81.
6. Lee WH, Morton RA, Epstein JI, et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994; 91:11733-7.
7. Bussemakers MJ, van Bokhoven A, Verhaegh GW, et al. DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999; 59:5975-9.
8. Rubin MA, Zhou M, Dhanasekaran SM, et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. Jama 2002; 287:1662-70.
9. Petrovics G, Liu A, Shaheduzzaman S, et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene 2005; 24:3847-52.
10. Teng CT. Lactoferrin gene expression and regulation: An overview. Biochem Cell Biol 2002; 80:7-16.
11. Brock JH. The physiology of lactoferrin. Biochem Cell Biol 2002; 80:1-6.
12. Damiens E, Mazurier J, el Yazidi I, et al. Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim Biophys Acta 1998; 1402:277-87.
13. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 1999; 74:486-98.
14. Yoo YC, Watanabe R, Koike Y, et al. Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: Involvement of reactive oxygen species. Biochem Biophys Res Commun 1997; 237:624-8.
15. Ward PP, Paz E, Conneely OM. Multifunctional roles of lactoferrin: A critical overview. Cell Mol Life Sci 2005; 62:2540-8.
16. Tsuda H, Sekine K, Fujita K, Ligo M. Cancer prevention by bovine lactoferrin and underlying mechanisms-A review of experimental and clinical studies. Biochem Cell Biol 2002; 80:131-6.
17. Sanchez L, Calvo M, Brock JH. Biological role of lactoferrin. Arch Dis Child 1992; 67:657-61.
18. Tsuda H, Sekine K, Ushida Y, et al. Milk and dairy products in cancer prevention: Focus on bovine lactoferrin. Mutat Res 2000; 462:227-33.
19. Tsuda H, Sekine K. Milk Components as Cancer Chemopreventive Agents. Asian Pac J Cancer Prev 2000; 1:277-82.
20. Tsuda H, Sekine K, Takasuka N, Toriyama-Baba H, Iigo M. Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals. Biofactors 2000; 12:83-8.
21. Fujita K, Ohnishi T, Sekine K, Iigo M, Tsuda H. Downregulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats. Jpn J Cancer Res 2002; 93:616-25.
22. Weng J, Wang J, Cai Y, et al. Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers. Int J Cancer 2005; 113:811-8.
23. Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005; 294(4):433-439.
24. Zou Z, Zhang W, Young D, et al. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation. Clin Cancer Res 2002; 8:1172-7.
25. Ehrich M, Nelson MR, Stanssens P, et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 2005; 102:15785-90.
26. Richter E MK, Cook C, Ehrich M, Tadese AY, Li H, Owusu A, Srivastava S, Dobi A. A role for DNA methylation in regulating the growth suppressor PMEPA1 gene in prostate cancer. Epigenetics 2007; In press.
27. Legrand D, Vigie K, Said EA, et al. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 2004; 271:303-17.
28. Naito S. Evaluation and management of prostate-specific antigen recurrence after radical prostatectomy for localized prostate cancer. Jpn J Clin Oncol 2005; 35:365-74.
29. Rhodes DR, Sanda MG, Otte AP, Chinnaiyan AM, Rubin MA. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J Natl Cancer Inst 2003; 95:661-8.
30. 1 cyclin-dependent kinases during growth arrest of head and neck cancer cells. Clin Cancer Res 2004; 10:8683-6.
31. Katunuma N, Le QT, Murata E, et al. A novel apoptosis cascade mediated by lysosomal lactoferrin and its participation in hepatocyte apoptosis induced by D-galactosamine. FEBS Lett 2006; 580:3699-705.
32. Furlong SJ, Mader JS, Hoskin DW. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen. Oncol Rep 2006; 15:1385-90.
33. Ushida Y, Sekine K, Kuhara T, Takasuka N, Iigo M, Tsuda H. Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc(Min) mouse. Cancer Lett 1998; 134:141-5.